Stock Taper
IMMP
IMMUTEP LIMITED
NASDAQ
$0.38
▲ UP 0.05% (0.00)

KEY STATISTICS

Market Cap$56.15 M
52w High$3.53
52w Low$0.29
Dividend Yield
Frequency
P/E-0.97
Volume181.02K
Shares Out.147.37M

COMPANY

LEADERSHIP

Marc Voigt
CHIEF EXECUTIVE
Marc Voigt

ABOUT

SECTOR
Healthcare
WENT PUBLIC
April 19, 2012
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
53

PRICE TARGET

Target High$5.00
Target Low$3.50
Target Median$4.25
Target Consensus$4.25

UPCOMING EARNINGS

DateSep 2, 2026
DayWednesday
Rev. Est.$11.72M
SEP
2
WED

SPLIT RECORD

DATETYPERATIO
2019-11-07Reverse1:10
2019-07-15Forward1011:1000
2016-12-28Reverse3:10

PRICE

$0.38 ▲ UP 0.05% (+$0.00)
OVERLAYS
$0.38$0.38$0.39$0.3910:25 AM11:21 AM12:16 PM1:12 PM2:08 PM3:03 PM3:59 PM0.38

About Immutep Limited

https://www.immutep.com ↗

Immutep Limited is an Australian biotech company developing immunotherapies for cancer and autoimmune diseases, with multiple clinical-stage products and collaborations with major pharma companies.

INDUSTRY

Biotechnology

A PRODUCT IMMUTEP LIMITED IS KNOWN FOR

Eftilagimod alpha (efti, IMP321)
Eftilagimod alpha (efti, IMP321)

Eftilagimod alpha is Immutep's lead soluble LAG-3 fusion protein immunotherapy, currently in multiple clinical trials including Phase III for non-small cell lung cancer, designed to activate antigen-presenting cells and stimulate anti-cancer immun...

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

DIRECTOR
Boyce Elisabeth Amanda
· —
2026-03-18
DIRECTOR
Boyce Elisabeth Amanda
· 296.0K shares
2028-12-01
DIRECTOR, OFFICER: SEE REMARKS
Voigt Marc
· —
2026-03-18
DIRECTOR, OFFICER: SEE REMARKS
Voigt Marc
· 1.2M shares
2028-12-01

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 1
NEUTRAL 1
MARKET PERFORM 1
3 GRADES IN THE LAST 12 MONTHS

SECTORS PEERS

PEERPRICE
CADL$13.07COMPARE
ACHV$8.10COMPARE
ALLO$2.02COMPARE
CAPR$9.59COMPARE
CABA$3.12COMPARE
EDIT$3.16COMPARE
VNDA$5.29COMPARE
TRDA$7.00COMPARE